Company Filing History:
Years Active: 2013
Title: The Innovations of Patrick Neuberg in Gene Silencing Technologies
Introduction
Patrick Neuberg, an innovative inventor based in Illkirch, France, has made significant contributions to the field of gene silencing through his research and inventions. His expertise lies in developing compositions for the transfection of oligonucleotides, an essential tool for biological studies and therapeutic applications.
Latest Patents
Neuberg holds a notable patent titled "Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications." This invention details compositions that facilitate the delivery of oligonucleotides into eukaryotic cells, both in culture and within living organisms. The patented compositions include an oligonucleotide and an amphiphilic cationic molecule, which can enhance the effectiveness of RNA interference mechanisms, paving the way for potential new therapeutic avenues.
Career Highlights
Patrick Neuberg is currently affiliated with Polyplus Transfection, a company renowned for its advancements in transfection technologies. His work focuses on the development of innovative solutions for gene therapy and molecular biology, reinforcing the importance of oligonucleotide delivery systems in modern science.
Collaborations
Throughout his career, Neuberg has collaborated with esteemed colleagues such as Anne-Laure Bolcato Bellemin and Jean-Paul Behr. Their joint efforts have contributed to advancing the understanding and utility of transfection methods, facilitating further innovations in the field.
Conclusion
In summary, Patrick Neuberg's contributions to gene silencing through his innovative patents and collaborations highlight his role as a pivotal figure in biotechnological advancements. His work continues to inspire and influence the development of effective therapeutic agents based on oligonucleotide delivery.